Target intelligence / Profile preview

Accessory gene regulator (agr) system (agr)

Target
agr
Molecular classification
Quorum-sensing system, Two-component system, Transcription factor, Signal transduction system
01

Overview

The Accessory gene regulator (agr) system is the master quorum-sensing apparatus in Staphylococcus aureus, regulating the transition from a colonizing to an invasive phenotype (Novick & Geisinger, 2008). It consists of the agrACDB operon, which produces an autoinducing peptide (AIP) that, upon reaching a threshold concentration, activates the AgrC-AgrA two-component signaling pathway (Otto, 2004). This activation triggers the transcription of RNAIII, the system's primary effector, which upregulates the production of secreted toxins (e.g., alpha-hemolysin) and enzymes while downregulating surface adhesins. The agr system is a significant target for anti-virulence therapies, such as Savirin and Solonamide B, which aim to suppress bacterial toxicity without exerting the strong selective pressure of traditional antibiotics (Gordon et al., 2013). However, the system's role is complex; agr dysfunction is associated with increased cell wall peptidoglycan thickness and the development of vancomycin-intermediate S. aureus (VISA) strains (Tan et al., 2018). Furthermore, loss of agr activity can promote biofilm formation and lead to persistent, chronic infections, presenting a major challenge for therapeutic intervention (Nielsen et al., 2014).

Other names
agr locusagr quorum sensing systemAccessory gene regulatoragrACDB operon
02

Mechanism of action

Inhibition of the AgrC-AgrA two-component signaling pathway to suppress the transition from a colonizing to an invasive phenotype by downregulating virulence factors like alpha-hemolysin and phenol-soluble modulins.

03

Biological functions

Quorum-sensingVirulence regulationSignal transductionBiofilm formationToxin productionCell wall metabolism regulation
04

Disease associations

InfectionSepsisSkin and soft tissue infectionPneumoniaEndocarditis
05

Safety considerations

Potential to promote biofilm formationAssociation of agr-dysfunction with vancomycin-intermediate S. aureus (VISA) phenotypesRisk of persistent or chronic infection due to reduced clearance of non-toxigenic bacteria
06

Interacting drugs

Savirin

5 more in the full profile.

07

Biomarkers

RNAIII expression levelsAlpha-hemolysin (Hla) productionPhenol-soluble modulin (PSM) levels

Beyond the preview

Go deeper on Accessory gene regulator (agr) system (agr).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Accessory gene regulator (agr) system (agr).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call